2003
DOI: 10.1128/cdli.10.5.744-750.2003
|View full text |Cite
|
Sign up to set email alerts
|

Method for Simultaneous Measurement of Antibodies to 23 Pneumococcal Capsular Polysaccharides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
78
0
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 92 publications
(80 citation statements)
references
References 22 publications
1
78
0
1
Order By: Relevance
“…Additionally, similar studies have been carried out using samples derived from various animal models (Keyes et al, 2003(Keyes et al, , 2002Hutchinson et al, 2001). The multiplex analysis capability of the Luminex technology is being adapted to other assays including antibody screening (Biagini et al, 2004(Biagini et al, , 2003Jones et al, 2002;Opalka et al, 2003;Pickering et al, 2002a,b;Martins, 2002), HLA typing Osowski et al, 2003;Chesterton et al, 2003;Brailey and Susskind, 2003), single nucleotide polymorphism or mutation analysis (Hutchings et al, 2003;Kube et al, 2003;Smith et al, 1998;Yang et al, 2001;Ye et al, 2001), and pathogen detection (Jenison et al, 2001;Earley et al, 2002;Dunbar et al, 2003;Cowan et al, 2004). The flexibility of this technology along with its inherent advantages suggests that additional applications will be forthcoming.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, similar studies have been carried out using samples derived from various animal models (Keyes et al, 2003(Keyes et al, , 2002Hutchinson et al, 2001). The multiplex analysis capability of the Luminex technology is being adapted to other assays including antibody screening (Biagini et al, 2004(Biagini et al, , 2003Jones et al, 2002;Opalka et al, 2003;Pickering et al, 2002a,b;Martins, 2002), HLA typing Osowski et al, 2003;Chesterton et al, 2003;Brailey and Susskind, 2003), single nucleotide polymorphism or mutation analysis (Hutchings et al, 2003;Kube et al, 2003;Smith et al, 1998;Yang et al, 2001;Ye et al, 2001), and pathogen detection (Jenison et al, 2001;Earley et al, 2002;Dunbar et al, 2003;Cowan et al, 2004). The flexibility of this technology along with its inherent advantages suggests that additional applications will be forthcoming.…”
Section: Discussionmentioning
confidence: 99%
“…This secondary antibody is either directly conjugated to the phycoerythrin (PE) fluorophore or biotin, which is then reacted with streptavidin-phycoerythrin. Although these technologies are gaining prominence and now have multiple commercial vendors for the analysis kits, there are relatively few reports of direct comparison between this technology and commercial ELISA kits (Camilla et al, 2001;Carson and Vignali, 1999;de Jager et al, 2003;Hildesheim et al, 2002;Hutchinson et al, 2001;Kellar et al, 2001;Oliver et al, 1998;Prabhakar et al, 2002;Vignali, 2000;Biagini et al, 2003). Only one of these reports utilizes commercially produced multiplex kits (Hildesheim et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…In comparative testings, MIA shows a comparable sensitivity to ELISA but an improved dynamic range (Vignali, 2000;Biagini et al, 2003;DuPont et al, 2005). Moreover, MIA is less labour-intensive and different analytes can be measured at the same time (Dasso et al, 2002;Biagini et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, MIA is less labour-intensive and different analytes can be measured at the same time (Dasso et al, 2002;Biagini et al, 2003). Also when compared to antibody microarrays, the Luminex technology has better features, such as a lower detection limit and a better dynamic range, although microarrays are more suitable for miniaturization (Rao et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…In the present study, we employed the microsphere as a solid phase to carry out the antigen-antibody reaction. The bead-based technique has been used in Multiplexed Fluorescent Microsphere Immunoassay [13] for the detection of various kinds of antigen and antibody, such as bacteria toxin [14], autoantigens in the serum of the patients [15] and specific antibodies against viral antigens [16]. The nature of the beads makes it possible to carry out immunoassay in a test tube and normal methods, such as stirring and votexing, can also be applied in both antibody immobilisation and antibody/antigen reaction.…”
Section: Discussionmentioning
confidence: 99%